IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy.
about
Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutideCost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden.Modeling the Long-Term Cost-Effectiveness of IDegLira in Patients with Type 2 Diabetes Who are Failing To Meet Glycemic Targets on Basal Insulin Alone in The Netherlands.Evaluation of the long-term cost-effectiveness of IDegLira versus liraglutide added to basal insulin for patients with type 2 diabetes failing to achieve glycemic control on basal insulin in the USA.Pharmacokinetic evaluation of fixed-ratio combination of insulin degludec and liraglutide in the treatment of type 2 diabetes.Pharmacotherapy of 'treatment resistant' type 2 diabetes.Fixed ratio combinations of glucagon like peptide 1 receptor agonists with basal insulin: a systematic review and meta-analysis.Cost-Effectiveness of IDegLira Versus Insulin Intensification Regimens for the Treatment of Adults with Type 2 Diabetes in the Czech Republic.Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes in the Slovak health system.Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes.Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting.Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
P2860
Q26751359-E096746B-0307-4489-BBC7-FFC4B228968BQ37689556-EE95171A-B9E2-4D97-A3B6-611439C3E80DQ38775589-8DD8AEE1-A0A8-4096-8676-57A996CEB756Q38907289-5C2CF84E-C805-406F-BC53-6C14503ADBD2Q38911124-6572BB33-5A1F-4D4B-BED8-C18BFA2DB6BCQ39170345-83817B52-F35C-4748-9334-47D4FE9FA9ABQ39236906-76E462FA-D725-4FD1-9F7B-3B5DD854D135Q47117737-054EA761-F362-4DFA-9334-7CFB156C9DC1Q47136443-8110738D-696B-4B91-9E93-596A55709C2EQ48097169-EC89FF18-2E49-412B-A453-E53F43041F45Q51241132-0613FAD3-C793-47AE-822E-7CCCA1060651Q52595142-1D12B4E2-FF55-497D-9D4B-06A1B016B168
P2860
IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
IDegLira Versus Alternative In ...... lled on Basal Insulin Therapy.
@ast
IDegLira Versus Alternative In ...... lled on Basal Insulin Therapy.
@en
type
label
IDegLira Versus Alternative In ...... lled on Basal Insulin Therapy.
@ast
IDegLira Versus Alternative In ...... lled on Basal Insulin Therapy.
@en
prefLabel
IDegLira Versus Alternative In ...... lled on Basal Insulin Therapy.
@ast
IDegLira Versus Alternative In ...... lled on Basal Insulin Therapy.
@en
P2093
P2860
P1433
P1476
IDegLira Versus Alternative In ...... lled on Basal Insulin Therapy.
@en
P2093
Jens Harald Kongsø
Kajsa Kvist
Muhammad Mamdani
Nick Freemantle
Stephen C Bain
P2860
P2888
P304
P356
10.1007/S13300-015-0142-Y
P577
2015-11-18T00:00:00Z